Certara/$CERT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Certara
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
Ticker
$CERT
Sector
Primary listing
Employees
1,517
Headquarters
Website
Certara Metrics
BasicAdvanced
$2B
255.18
$0.05
1.43
-
Price and volume
Market cap
$2B
Beta
1.43
52-week high
$15.69
52-week low
$8.64
Average daily volume
1.9M
Financial strength
Current ratio
2.157
Quick ratio
2.065
Long term debt to equity
28.314
Total debt to equity
28.998
Interest coverage (TTM)
1.63%
Profitability
EBITDA (TTM)
104.733
Gross margin (TTM)
61.14%
Net profit margin (TTM)
1.97%
Operating margin (TTM)
7.96%
Effective tax rate (TTM)
29.45%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
1.31%
Return on equity (TTM)
0.76%
Valuation
Price to earnings (TTM)
255.175
Price to revenue (TTM)
5.019
Price to book
1.9
Price to tangible book (TTM)
-11.89
Price to free cash flow (TTM)
26.288
Free cash flow yield (TTM)
3.80%
Free cash flow per share (TTM)
0.482
Growth
Revenue change (TTM)
11.61%
Earnings per share change (TTM)
-109.95%
3-year revenue growth (CAGR)
8.97%
3-year earnings per share growth (CAGR)
-9.77%
What the Analysts think about Certara
Analyst ratings (Buy, Hold, Sell) for Certara stock.
Bulls say / Bears say
Q1 2025 revenue grew 10% YoY to $106.0 million, led by an 18% increase in software revenue, reflecting rising adoption of Certara’s biosimulation platform. (Certara Press Release)
Board’s authorization of a $100 million share repurchase program underscores management confidence in the company’s growth prospects and may provide EPS accretion. (RTTNews)
Relative Strength (RS) Rating upgraded from 80 to 87, placing Certara among the top technical performers in its industry and suggesting sustained stock momentum. (Investors.com)
Services revenue grew only 4% YoY to $59.6 million in Q1 2025, significantly lagging the software segment and highlighting potential softness in its service offerings. (Certara Press Release)
Reiterated 2025 revenue guidance of $415 million–$425 million implies mid-single-digit growth in H2, indicating a slowdown from Q1’s 10% growth rate. (RTTNews)
Ongoing strategic review of the regulatory services business and preliminary third-party discussions could introduce execution risk and near-term revenue volatility. (SEC.gov)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Certara Financial Performance
Revenues and expenses
Certara Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Certara stock?
Certara (CERT) has a market cap of $2B as of October 26, 2025.
What is the P/E ratio for Certara stock?
The price to earnings (P/E) ratio for Certara (CERT) stock is 255.18 as of October 26, 2025.
Does Certara stock pay dividends?
No, Certara (CERT) stock does not pay dividends to its shareholders as of October 26, 2025.
When is the next Certara dividend payment date?
Certara (CERT) stock does not pay dividends to its shareholders.
What is the beta indicator for Certara?
Certara (CERT) has a beta rating of 1.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.